Sumiya Sharmin Mou

Sumiya Sharmin Mou

Auto-generated profile, based on publicly available information

Sumiya Sharmin Mou

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Pharmacy & Pharmacology International Journal
Verified
Journal Article
Open access
PDF file
SMSumiya Sharmin Mou
Sumiya Sharmin Mou
SASeagufta Afrin
Seagufta Afrin
RIRakibul Islam
Rakibul Islam
EAElias Al-Mamun
Elias Al-Mamun
FZFatema Tuz Zohora
Fatema Tuz Zohora
This study aims to evaluate the quality parameters of the immediate release Ketorolac tromethamine (KT) 10 mg tablet of different local brands available in Bangladesh. The evaluation was done in compliance to various Pharmacopeial quality parameters, i.e., weight variation, friability, hardness, thickness, disintegration, potency, and dissolution. Six formulations of KT were prepared by direct compression method using different super disintegrants. Micrometric properties of the mixtures of the drug and the excipients prepared for formulation were evaluated. Quality evaluation of the six different formulations and randomly selected six different brands of KT 10-mg tablets purchased from the local market were performed according to Pharmacopoeia. The results were obtained by UV-Vis spectrophotometer and all the dissolution profiles were characterized by the zero order kinetics. All the brands of KT and developed formulations met the official specification with some fluctuations in the range. The marketed ketorolac tablet's potency ranged from 93% to 97% and formulated tablets is 91.15%. The values obtained from the tests were used to analyze the degree of conformance of commercially available drugs to the USP specification that represents the quality of both commercially available and formulated tablets. All the parameters comply with the USP specifications which ensure the safe usage of ketorolac tablets in Bangladeshi population that doesn’t compromise with the quality.

31 March 2025 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
SMSumiya Sharmin Mou
Sumiya Sharmin Mou
FZFatema- Tuz- Zohora
Fatema- Tuz- Zohora
SASeagufta Afrin
Seagufta Afrin
STSolaiman Hossain Tuhin
Solaiman Hossain Tuhin
DMDr. Abdul Abdul Muhit
Dr. Abdul Abdul Muhit
FAFiroj Ahmed
Firoj Ahmed
This study evaluates the chemical and biological properties of Pterocarpus santalinus leaf methanolic extract to establish its scientific basis for potential therapeutic applications. The phytochemical analysis revealed the presence of 595.04 mg/g flavonoids (quercetin equivalent) and 69 mg/g phenolic compounds (gallic acid equivalent), underscoring its antioxidant potential. The extract exhibited DPPH radical scavenging activity with an IC50 of 337.79 µg/ml, indicating moderate antioxidant capacity. Additionally, mild antimicrobial activity was observed against Escherichia coli and Aspergillus niger. The cytotoxic effects of the extract were assessed in HeLa cells, demonstrating a concentration-dependent relationship. At concentrations of 100 µg/ml and 200 µg/ml, cell viability remained above 95%, indicating non-toxic effects. However, at 500 µg/ml, a significant decrease in cell viability to 20-30% was observed, with an LC50 value of 365.77 µg/ml, indicating substantial cytotoxicity at higher concentrations. These results suggest that while lower concentrations are safe, higher doses may induce cell death, necessitating the establishment of safe dosage ranges for therapeutic applications. The findings support the pharmacological potential of P. santalinus leaf extract, highlighting its relevance in antioxidant, antimicrobial, and anticancer research, and warrant further investigation to refine its medicinal applications.

1 January 2025 in MOJ Public Health
Verified
Journal Article
Open access
PDF file
TTTasnuma Tabassum
Tasnuma Tabassum
AFAdeeba Jaheen Faruqui
Adeeba Jaheen Faruqui
SMSumiya Sharmin Mou
Sumiya Sharmin Mou
Nasiba Binte BaharNasiba Binte Bahar
Nasiba Binte Bahar
FZFatema Tuz Zohora
Fatema Tuz Zohora
EAElias Al-Mamun
Elias Al-Mamun
COVID-19 has been a public health crisis for quite a long time worldwide. Providing primary health care during this has proven to be quite difficult. Telemedicine played an imperative part in this by minimizing virus spread and utilizing the time of healthcare experts. This survey was designed to know about the prevalence of telemedicine during Covid-19 pandemic as well as its future prospect in Bangladesh. Four stakeholders were categorized for the study: common people, physicians, pharmaceutical professionals and regulatory body. Data was collected both via online and offline. Among the general people, 50.23% took health services through telemedicine service during the pandemic and 24.64% before the pandemic. Both general people (78.88%) and physicians (60%) expressed their satisfaction regarding the service. 93% pharmaceutical professionals also suggested that telemedicine should be implemented in all hospitals. Among the service takers 100% people were prescribed cold medicines. 58% of the respiratory issues were addressed through telemedicine. Physicians as well as regulatory authority considered raising awareness about telemedicine to be an important factor. Therefore, telemedicine should be utilized in several ways in our health sector. The post-Covid-19 era presents a unique opportunity for Bangladesh to harness the potential of telemedicine in addressing healthcare disparities and improving access to quality care. While challenges persist, strategic investments, technological innovation, and policy support can ensure that telemedicine becomes a cornerstone of a more equitable and efficient healthcare system in Bangladesh.